Search research articles
Contact Us
Filters
Showing results (21-30 of 122) with videos related to
Page
of 13
Sort By:
The Journal of Surgical Research
|
April 1, 1993
IL-1 receptor antagonist (IL-1ra) augments IL-2-induced pulmonary vascular leak
A K Thom, D L Fraker, J A Norton
Archives of Surgery (Chicago, Ill. : 1960)
|
January 1, 1989
Cachectin activity in the serum of cachectic, tumor-bearing rats
M C Stovroff, D L Fraker, J A Norton
Journal of the American Academy of Dermatology
|
January 1, 1984
Necrotizing vasculitis from radiographic contrast media
F A Kerdel, D L Fraker, H A Haynes
Circulatory Shock
|
September 1, 1994
Use of tumor necrosis factor in isolated hepatic perfusion
D L Fraker, H R Alexander, A K Thom
The Journal of Experimental Medicine
|
September 1, 1989
Passive immunization against tumor necrosis factor partially abrogates interleukin 2 toxicity
D L Fraker, H N Langstein, J A Norton
Surgery
|
August 1, 1989
Prevention and treatment of endotoxin and sepsis lethality with recombinant human tumor necrosis factor
B C Sheppard, D L Fraker, J A Norton
The American Journal of Physiology
|
June 1, 1989
Reversal of the toxic effects of cachectin by concurrent insulin administration
D L Fraker, M J Merino, J A Norton
Cancer Research
|
April 15, 1990
Impact of tolerance on antitumor efficacy of tumor necrosis factor in mice
D L Fraker, B C Sheppard, J A Norton
The Journal of Urology
|
May 23, 1998
Renal cell carcinoma presenting with mesenteric thrombosis and anticardiolipin antibodies: echoes of Trousseau's syndrome?
R F Sánchez-Ortiz, D L Fraker, S B Malkowicz
The Cancer Journal From Scientific American
|
July 1, 1995
Palliation of regional symptoms of advanced extremity melanoma by isolated limb perfusion with melphalan and high-dose tumor necrosis factor
D L Fraker, H R Alexander, M Andrich, et al.
Page
of 13
Search research articles
Search
Showing results (21-30 of 122) with videos related to
Sort By:
Page
of 13
The Journal of Surgical Research
|
April 1, 1993
IL-1 receptor antagonist (IL-1ra) augments IL-2-induced pulmonary vascular leak
A K Thom, D L Fraker, J A Norton
Archives of Surgery (Chicago, Ill. : 1960)
|
January 1, 1989
Cachectin activity in the serum of cachectic, tumor-bearing rats
M C Stovroff, D L Fraker, J A Norton
Journal of the American Academy of Dermatology
|
January 1, 1984
Necrotizing vasculitis from radiographic contrast media
F A Kerdel, D L Fraker, H A Haynes
Circulatory Shock
|
September 1, 1994
Use of tumor necrosis factor in isolated hepatic perfusion
D L Fraker, H R Alexander, A K Thom
The Journal of Experimental Medicine
|
September 1, 1989
Passive immunization against tumor necrosis factor partially abrogates interleukin 2 toxicity
D L Fraker, H N Langstein, J A Norton
Surgery
|
August 1, 1989
Prevention and treatment of endotoxin and sepsis lethality with recombinant human tumor necrosis factor
B C Sheppard, D L Fraker, J A Norton
The American Journal of Physiology
|
June 1, 1989
Reversal of the toxic effects of cachectin by concurrent insulin administration
D L Fraker, M J Merino, J A Norton
Cancer Research
|
April 15, 1990
Impact of tolerance on antitumor efficacy of tumor necrosis factor in mice
D L Fraker, B C Sheppard, J A Norton
The Journal of Urology
|
May 23, 1998
Renal cell carcinoma presenting with mesenteric thrombosis and anticardiolipin antibodies: echoes of Trousseau's syndrome?
R F Sánchez-Ortiz, D L Fraker, S B Malkowicz
The Cancer Journal From Scientific American
|
July 1, 1995
Palliation of regional symptoms of advanced extremity melanoma by isolated limb perfusion with melphalan and high-dose tumor necrosis factor
D L Fraker, H R Alexander, M Andrich, et al.
Page
of 13